Zacks Research Has Weak Outlook for Haemonetics Q1 Earnings
Haemonetics Co. (NYSE:HAE – Free Report) – Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for shares of Haemonetics in a research report issued to clients and investors on Thursday, June 5th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earnings of $1.01 per share for […]
Haemonetics Co. (NYSE:HAE – Free Report) – Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for shares of Haemonetics in a research report issued to clients and investors on Thursday, June 5th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earnings of $1.01 per share for […]
